Tech Company Financing Transactions
Sinopia Biosciences Funding Round
On 10/21/2026, Sinopia Biosciences secured $2.5 million in funding from National Institutes of Health.
Transaction Overview
Company Name
Announced On
10/21/2026
Transaction Type
Debt
Amount
$2,500,000
Round
Undisclosed
Investors
Proceeds Purpose
The award will support the development and validation of an AI-powered metabolomics foundation model designed to integrate data generated across different experimental platforms and analytical methods, enabling Sinopia to leverage diverse datasets for drug discovery through its proprietary LEADS® (LEarn And DiScover) platform.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3210 Merryfield Row
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Our mission is to transform the treatment of complex diseases utilizing novel discoveries empowered by artificial intelligence and omics data. We develop advanced deep learning algorithms to analyze complex biological data, revealing novel therapeutic targets and drug candidates. Enabled by our proprietary platform, we have decoded molecular mechanisms and identified therapeutic opportunities to restore brain health in Parkinson's disease. At Sinopia, we unite data science innovation, deep biological insight, and a commitment to patients to accelerate the discovery of breakthrough treatments that change the course of Parkinson's disease and improve lives.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Arthur Suckow
Chief Executive Officer
Aarash Bordbar
Chief Marketing Officer
Tanya Simuni
Chief Operating Officer
Iman Famili
Co-Founder
Bernhard Palsson
Browse more venture capital transactions:
Prev: 10/20/2026: Sunlight AI venture capital transaction
Next: 10/21/2026: Drove Aeropower venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs